Red de Ciencia y Desarrollo
Noticias, opiniones e información sobre ciencia, tecnología y el mundo en desarrollo
Noticias
Pakistan orders fresh trials on local hepatitis drug
3 febrero 2011 | EN
Pakistan has ordered fresh clinical trials on local hepatitis b drug
CDC
Pakistan's ministry of health has ordered new clinical trials on a locally made hepatitis B drug that ran into controversy over corruption charges and trial irregularities.
The local drug for hepatitis B, which affects seven million persons in the country, was developed at the Lahore-based Centre of Advanced Molecular Biology (CAMB).
But, controversy has dogged the drug trials and launch. Pakistan's science ministry has charged CAMB with funds misuse during drug development, and referred its audit findings on CAMB to the country’s Federal Investigation Agency.
The health ministry says CAMB conducted studies on humans without permission, and used a small sample size.
Last month (10 January), the health ministry told the CAMB to conduct fresh clinical trials and initiate steps to produce 100,000 vials of the drug.
AGREGUE SU COMENTARIO
Por favor, espere
Todos los comentarios están sujetos a revisión. Nos reservamos el derecho de editar los comentarios que contengan un lenguaje inapropiado o inadecuado. SciDev.Net mantiene los derechos de autor de todo el material que se publica en el portal. Por favor lea las condiciones de uso para más detalles.
Todo el material de SciDev.Net se puede reproducir gratuitamente siempre que se de crédito a la fuente y al autor. Para más detalles ver Creative commons.
1 junio 2012